DAI-10 is as good as DAI-30 in schizophrenia.
René Ernst Nielsen, Eva Lindström, Jimmi Nielsen, Sten Levander
Index: Eur. Neuropsychopharmacol. 22(10) , 747-50, (2012)
Full Text: HTML
Abstract
Drug attitude inventory (DAI-30) is considered to be the best predictor of poor adherence in first-episode schizophrenia. We compared the short version (DAI-10) with DAI-30 in long-term schizophrenia, documented if DAI was associated with poor insight, PANSS and GAF and constructed DAI-10 percentiles. DAI-30 and DAI-10 were homogenous (r = 0.82 and 0.72, respectively) with good test-retest reliability (0.79). The correlation between the DAI versions was high (0.94). Percentile scores of DAI-10 were computed. DAI is an easy-to-use self-report instrument seemingly assessing a unique clinical dimension relevant to non-adherence. DAI-10 might be preferred for its simplicity and good psychometric properties.Copyright © 2012 Elsevier B.V. and ECNP. All rights reserved.
Related Compounds
Related Articles:
An investigation of the stability of emerging new psychoactive substances.
2014-01-01
[Drug Test. Anal. 6(7-8) , 696-704, (2014)]
2012-12-01
[Eur. J. Neurosci. 36(12) , 3628-35, (2012)]
Risperidone versus other atypical antipsychotics for schizophrenia.
2011-01-01
[Cochrane Database Syst. Rev. (1) , CD006626, (2011)]
Sertindole in the management of schizophrenia.
2011-01-01
[J. Cent. Nerv. Syst. Dis. 3 , 75-85, (2011)]
Risperidone treatment increases CB1 receptor binding in rat brain.
2010-01-01
[Neuroendocrinology 91(2) , 155-68, (2010)]